Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 5th edition, 486 pages

Free download


  Free Subscription


3 Am J Obstet Gynecol
12 Am J Respir Crit Care Med
9 Ann Intern Med
1 Antiviral Res
26 BMJ
6 Br J Anaesth
17 Clin Infect Dis
14 Emerg Infect Dis
2 Eur J Radiol
11 Infect Control Hosp Epidemiol
17 Int J Infect Dis
5 Intensive Care Med
11 J Infect
16 J Med Virol
2 J Travel Med
1 J Virol
5 Lancet
8 Lancet Glob Health
3 Lancet Infect Dis
2 Lancet Neurol
2 Lancet Oncol
1 Lancet Planet Health
6 Lancet Psychiatry
10 Lancet Respir Med
2 Life Sci
6 MMWR Morb Mortal Wkly Rep
4 N Engl J Med
9 Nature
1 Pol J Radiol
3 Radiology
5 Science
6 Travel Med Infect Dis

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Obstet Gynecol

  1. MAIN EK, Chang SC, Carpenter AM, Wise PH, et al
    Singleton preterm birth rates for racial and ethnic groups during the coronavirus disease 2019 pandemic in California.
    Am J Obstet Gynecol. 2020 Oct 23. pii: S0002-9378(20)31208.

  2. VOLPATO F, Dos Santos LG, Dos Santos EM
    Coronavirus and its controversial results during pregnancy.
    Am J Obstet Gynecol. 2020 Nov 17. pii: S0002-9378(20)31311.

  3. RASMUSSEN SA, Jamieson DJ
    COVID-19 and Pregnancy - Reply.
    Am J Obstet Gynecol. 2020 Nov 17. pii: S0002-9378(20)31305.

    Am J Respir Crit Care Med

  4. JUN J, Kelly Costa D
    Supporting a Precious Resource: Healthcare Clinicians.
    Am J Respir Crit Care Med. 2020;202:1330-1332.

  5. CHIANG KC, Gupta A
    Transpulmonary Bubble Transit in Severe COVID-19: Pulmonary Vasodilatation or Angiogenesis?
    Am J Respir Crit Care Med. 2020 Nov 18. doi: 10.1164/rccm.202009-3642.

  6. SWENSON ER, Hopkins SR, Stickland MK
    Positive Bubble Study in Severe COVID-19: Bubbles May be Unrelated to Gas Exchange Impairment.
    Am J Respir Crit Care Med. 2020 Nov 18. doi: 10.1164/rccm.202010-3800.

  7. ANGRIMAN F, Scales DC
    Estimating the Case Fatality Risk of COVID-19 Among Mechanically Ventilated Patients.
    Am J Respir Crit Care Med. 2020 Nov 18. doi: 10.1164/rccm.202011-4117.

  8. REYNOLDS AS, Lee AG, Renz J, DeSantis K, et al
    Reply to: Chiang et al and Swenson et al.
    Am J Respir Crit Care Med. 2020 Nov 18. doi: 10.1164/rccm.202010-3974.

  9. ALTHUWAYBI A, Al Quaimi M, Krishnan A, Jones R, et al
    Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease; a Potential Role for Aerodigestive Pathophysiology?
    Am J Respir Crit Care Med. 2020 Nov 20. doi: 10.1164/rccm.202010-4031.

  10. CHAUDHURI N, George PM, Kreuter M, Molina-Molina M, et al
    Reply to: Hospitalization Outcomes for COVID-19 in Patients with Interstitial Lung Disease; a Potential Role for Aerodigestive Pathophysiology?
    Am J Respir Crit Care Med. 2020 Nov 20. doi: 10.1164/rccm.202011-4146.

  11. DORWARD DA, Russell CD, Um IH, Elshani M, et al
    Tissue-specific Immunopathology in Fatal COVID-19.
    Am J Respir Crit Care Med. 2020 Nov 20. doi: 10.1164/rccm.202008-3265.
    PubMed         Abstract available

  12. MORAIS CCA, Safaee Fakhr B, De Santis Santiago RR, Di Fenza R, et al
    Bedside Electrical Impedance Tomography Unveils Respiratory "Chimera" in COVID-19.
    Am J Respir Crit Care Med. 2020 Nov 16. doi: 10.1164/rccm.202005-1801.

    What Is "the Flu"?
    Am J Respir Crit Care Med. 2020;202:P21-P22.

  14. SOCKRIDER M, Corn J, Krishnan V
    Socializing During the COVID-19 Pandemic.
    Am J Respir Crit Care Med. 2020 Nov 18. doi: 10.1164/rccm.2020.

    Novel Phenotypes in Respiratory Failure: Same As It Ever Was.
    Am J Respir Crit Care Med. 2020;202:1207-1209.

    Ann Intern Med

  16. RIVA MA, Paladino ME, Belingheri M
    The Role of Medical Students During the COVID-19 Pandemic.
    Ann Intern Med. 2020;173:858-859.

  17. MANSOUR O, Tajanlangit M, Heyward J, Mojtabai R, et al
    Telemedicine and Office-Based Care for Behavioral and Psychiatric Conditions During the COVID-19 Pandemic in the United States.
    Ann Intern Med. 2020 Nov 17. doi: 10.7326/M20-6243.

  18. ROCHWERG B, Schunemann HJ, Akl EA
    Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19.
    Ann Intern Med. 2020;173:860.

    Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19.
    Ann Intern Med. 2020;173:860.

  20. MILLER DG, Pierson L, Doernberg S
    The Role of Medical Students During the COVID-19 Pandemic.
    Ann Intern Med. 2020;173:859.

  21. LAWANDI A, Danner RL
    Antibody tests have higher sensitivity at >/=15 days after symptom onset and 99% specificity for detecting SARS-CoV-2.
    Ann Intern Med. 2020;173:JC57.
    PubMed         Abstract available

  22. LAINE C, Goodman SN, Guallar E
    The Role of Masks in Mitigating the SARS-CoV-2 Pandemic: Another Piece of the Puzzle.
    Ann Intern Med. 2020 Nov 18. doi: 10.7326/M20-7448.

  23. DAL-RE R, Caplan AL, Gluud C, Porcher R, et al
    Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 Vaccine.
    Ann Intern Med. 2020 Nov 20. doi: 10.7326/M20-7357.

  24. BUNDGAARD H, Bundgaard JS, Raaschou-Pedersen DET, von Buchwald C, et al
    Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers : A Randomized Controlled Trial.
    Ann Intern Med. 2020 Nov 18. doi: 10.7326/M20-6817.
    PubMed         Abstract available

    Antiviral Res

  25. ZHANG Y, Song W, Chen S, Yuan Z, et al
    A bacterial artificial chromosome (BAC)-vectored noninfectious replicon of SARS-CoV-2.
    Antiviral Res. 2020 Nov 17:104974. doi: 10.1016/j.antiviral.2020.104974.
    PubMed         Abstract available


    Covid-19: Government has spent billions on contracts with little transparency, watchdog says.
    BMJ. 2020;371:m4474.

  27. WATSON MC, Coufopoulos A
    Covid-19 test and trace: localised approach urgently needed.
    BMJ. 2020;371:m4389.

    Covid-19: Governments should demand transparency on vaccine deals, says MSF.
    BMJ. 2020;371:m4430.

    Covid-19: North Dakota and Belgium have let infected health staff work on wards.
    BMJ. 2020;371:m4455.

    Covid-19: Third candidate vaccine will be tested in UK.
    BMJ. 2020;371:m4451.

    Screening the healthy population for covid-19 is of unknown value, but is being introduced nationwide.
    BMJ. 2020;371:m4438.

    Covid-19: Excess deaths vary widely across England and Wales, show data.
    BMJ. 2020;371:m4500.

  33. MAHASE E
    Covid-19: UK government faces legal action after awarding pound250m in PPE contracts to jewellery company.
    BMJ. 2020;371:m4489.

  34. WISE J
    Covid-19: Critically ill patients treated with arthritis drug tocilizumab show improved outcomes, researchers report.
    BMJ. 2020;371:m4530.

  35. RIMMER A
    Covid-19: Government must reduce social mixing after lockdown, says BMA.
    BMJ. 2020;371:m4522.

  36. HSU J
    Covid-19: What now for remdesivir?
    BMJ. 2020;371:m4457.

  37. Update to living WHO guideline on drugs for covid-19.
    BMJ. 2020;371:m4475.

  38. GILL M, Gray M
    Mass testing for covid-19 in the UK.
    BMJ. 2020;371:m4436.

  39. HODES S
    Covid-19 communication-a matter of life and death?
    BMJ. 2020;371:m4390.

    Covid:19: Italy has wasted the sacrifices of the first wave, say experts.
    BMJ. 2020;371:m4279.

  41. PEER AMJ
    Telemedicine: don't discount the value of in-person GP clinics to the medical trainee.
    BMJ. 2020;371:m4340.

  42. BHATT N
    Covid-19: Government's tacit approval of traditional medicine treatments alarms India's doctors.
    BMJ. 2020;371:m4319.

    A US election victory for science and public health.
    BMJ. 2020;371:m4325.

    Covid-19: Government faces legal action over pound75m contract for antibody tests.
    BMJ. 2020;371:m4427.

  45. MAHASE E
    Covid-19: Pfizer and BioNTech submit vaccine for US authorisation.
    BMJ. 2020;371:m4552.

  46. DYER C
    Covid-19: UK government response was overcentralised and poorly communicated, say peers.
    BMJ. 2020;371:m4445.

  47. JOHN A, Pirkis J, Gunnell D, Appleby L, et al
    Trends in suicide during the covid-19 pandemic.
    BMJ. 2020;371:m4352.

    Covid-19: Government buried negative data on its favoured antibody test.
    BMJ. 2020;371:m4353.

  49. LEIS JA, Born KB, Theriault G, Ostrow O, et al
    Using antibiotics wisely for respiratory tract infection in the era of covid-19.
    BMJ. 2020;371:m4125.

  50. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: development and validation of the 4C Mortality Score.
    BMJ. 2020;371:m4334.

  51. ABBASI K
    Covid-19: politicisation, "corruption," and suppression of science.
    BMJ. 2020;371:m4425.

    Br J Anaesth

  52. BAKER HA, Safavynia SA, Evered LA
    The 'third wave': impending cognitive and functional decline in COVID-19 survivors.
    Br J Anaesth. 2020 Oct 21. pii: S0007-0912(20)30849.

  53. ASCOTT A, Crowest P, de Sausmarez E, Khan M, et al
    Respiratory personal protective equipment for healthcare workers: impact of sex differences on respirator fit test results.
    Br J Anaesth. 2020 Oct 21. pii: S0007-0912(20)30851.

  54. SPERNA WEILAND NH, Traversari RAAL, Sinnige JS, van Someren Greve F, et al
    Influence of room ventilation settings on aerosol clearance and distribution.
    Br J Anaesth. 2020 Oct 23. pii: S0007-0912(20)30853.

  55. JAIN A, Lamperti M, Doyle DJ
    Dexmedetomidine: another arrow in the quiver to fight COVID-19 in intensive care units.
    Br J Anaesth. 2020 Oct 14. pii: S0007-0912(20)30842.

  56. PERELLA P, Tabarra M, Hataysal E, Pournasr A, et al
    Minimising exposure to droplet and aerosolised pathogens: a computational fluid dynamics study.
    Br J Anaesth. 2020 Nov 16. pii: S0007-0912(20)30855.
    PubMed         Abstract available

  57. PIRRACCHIO R, Mavrothalassitis O, Mathis M, Kheterpal S, et al
    Response of US hospitals to elective surgical cases in the COVID-19 pandemic.
    Br J Anaesth. 2020 Oct 19. pii: S0007-0912(20)30847.

    Clin Infect Dis

    COVID-19 disease spectrum in children - first insights from Africa.
    Clin Infect Dis. 2020 Nov 14. pii: 5981678. doi: 10.1093/cid/ciaa1731.

  59. LEWIS NM, Chu VT, Ye D, Conners EE, et al
    Household Transmission of SARS-CoV-2 in the United States.
    Clin Infect Dis. 2020 Aug 16. pii: 5893024. doi: 10.1093/cid/ciaa1166.
    PubMed         Abstract available

  60. MCLAUGHLIN JM, Khan F, Pugh S, Angulo FJ, et al
    County-Level Predictors of COVID-19 Cases and Deaths in the United States: What Happened, and Where Do We Go from Here?
    Clin Infect Dis. 2020 Nov 19. pii: 5992242. doi: 10.1093/cid/ciaa1729.
    PubMed         Abstract available

  61. QIN G, Zhang L, Yu CJ
    Nonpharmaceutical Interventions and Epidemic Intensity During the 2019 Novel Coronavirus Disease Pandemic.
    Clin Infect Dis. 2020;71:2019-2020.

  62. PELUSO MJ, Bakkour S, Busch MP, Deeks SG, et al
    A High Percentage of People with HIV on Antiretroviral Therapy Experience Detectable Low-Level Plasma HIV-1 RNA Following COVID-19.
    Clin Infect Dis. 2020 Nov 19. pii: 5991913. doi: 10.1093/cid/ciaa1754.

    The misleading "pooled effect estimate" of crude data from observational studies at critical risk of bias: The case of Tocilizumab in COVID-19.
    Clin Infect Dis. 2020 Nov 17. pii: 5985641. doi: 10.1093/cid/ciaa1735.

  64. AMIN-CHOWDHURY Z, Aiano F, Mensah A, Sheppard C, et al
    Impact of the COVID-19 Pandemic on Invasive Pneumococcal Disease and Risk of Pneumococcal Coinfection with SARS-CoV-2: prospective national cohort study, England.
    Clin Infect Dis. 2020 Nov 16. pii: 5983410. doi: 10.1093/cid/ciaa1728.
    PubMed         Abstract available

  65. EMANUELS A, Heimonen J, O'Hanlon J, Kim AE, et al
    Remote Household Observation for Non-influenza Respiratory Viral Illness.
    Clin Infect Dis. 2020 Nov 17. pii: 5983780. doi: 10.1093/cid/ciaa1719.
    PubMed         Abstract available

  66. ZHANG AJ, Lee AC, Chan JF, Liu F, et al
    Co-infection by severe acute respiratory syndrome coronavirus 2 and influenza A(H1N1)pdm09 virus enhances the severity of pneumonia in golden Syrian hamsters.
    Clin Infect Dis. 2020 Nov 20. pii: 5995847. doi: 10.1093/cid/ciaa1747.
    PubMed         Abstract available

  67. VAN DEN BORST B, Peters JB, Brink M, Schoon Y, et al
    Comprehensive health assessment three months after recovery from acute COVID-19.
    Clin Infect Dis. 2020 Nov 21. pii: 5998118. doi: 10.1093/cid/ciaa1750.
    PubMed         Abstract available

  68. MEYEROWITZ EA, Sen P, Schoenfeld SR, Neilan TG, et al
    Immunomodulation as Treatment for Severe COVID-19: a systematic review of current modalities and future directions.
    Clin Infect Dis. 2020 Nov 20. pii: 5996142. doi: 10.1093/cid/ciaa1759.
    PubMed         Abstract available

  69. BHATT PJ, Shiau S, Brunetti L, Xie Y, et al
    Risk Factors and Outcomes of Hospitalized Patients with Severe COVID-19 and Secondary Bloodstream Infections: A Multicenter, Case-Control Study.
    Clin Infect Dis. 2020 Nov 20. pii: 5995838. doi: 10.1093/cid/ciaa1748.
    PubMed         Abstract available

  70. LEE JS, Kim SY, Kim TS, Hong KH, et al
    Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.
    Clin Infect Dis. 2020 Nov 21. pii: 5997517. doi: 10.1093/cid/ciaa1421.
    PubMed         Abstract available

    SARS-CoV-2 Antibody Testing: Important but Imperfect.
    Clin Infect Dis. 2020 Nov 18. pii: 5989218. doi: 10.1093/cid/ciaa1755.

  72. LADHANI SN, Andrews N, Aiano F, Baawuah F, et al
    Secondary attack rate and family clustering of SARS-CoV-2 infection in children of healthcare workers with confirmed COVID-19.
    Clin Infect Dis. 2020 Nov 17. pii: 5985642. doi: 10.1093/cid/ciaa1737.
    PubMed         Abstract available

  73. HUANG YT, Chao CM, Lai CC
    The impact of tocilizumab on the mortality of patients with COVID-19.
    Clin Infect Dis. 2020 Nov 17. pii: 5985678. doi: 10.1093/cid/ciaa1738.

  74. RUSSO A, Bellelli V, Ceccarelli G, Marincola Cattaneo F, et al
    Comparison between hospitalized patients affected or not by COVID-19 (RESILIENCY study).
    Clin Infect Dis. 2020 Nov 18. pii: 5989494. doi: 10.1093/cid/ciaa1745.

    Emerg Infect Dis

  75. HOPEWELL PC, Reichman LB, Castro KG
    Parallels and Mutual Lessons in Tuberculosis and COVID-19 Transmission, Prevention, and Control.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  76. LIM SYD, Tey HL
    Large-Scale Isolation Facilities and Potential for Secondary Infectious Disease Outbreak.
    Emerg Infect Dis. 2020;27.

  77. YAN G, Ang A, Tham SM, Ng A, et al
    Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan.
    Emerg Infect Dis. 2020;27.

  78. PERETTI-WATEL P, Seror V, Cortaredona S, Launay O, et al
    Attitudes about COVID-19 Lockdown among General Population, France, March 2020.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  79. WANG H, Hogan CA, Miller JA, Sahoo MK, et al
    Performance of Nucleic Acid Amplification Tests for Detection of Severe Acute Respiratory Syndrome Coronavirus 2 in Prospectively Pooled Specimens.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  80. STONOGA ETS, de Almeida Lanzoni L, Rebutini PZ, Permegiani de Oliveira AL, et al
    Intrauterine Transmission of SARS-CoV-2.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  81. DUY C, Nong VM, Van Ngo A, Doan TT, et al
    Nosocomial Coronavirus Disease Outbreak Containment, Hanoi, Vietnam, March-April 2020.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  82. SHIMOTSU ST, Johnson ARL, Berke EM, Griffin DO, et al
    COVID-19 Infection Control Measures in Long-Term Care Facility, Pennsylvania, USA.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

  83. HAMMER AS, Quaade ML, Rasmussen TB, Fonager J, et al
    SARS-CoV-2 Transmission between Mink (Neovison vison) and Humans, Denmark.
    Emerg Infect Dis. 2020;27.
    PubMed         Abstract available

    Large SARS-CoV-2 Outbreak Caused by Asymptomatic Traveler, China.
    Emerg Infect Dis. 2020;26:3106.

  85. HEMIDA MG, Chu DKW, Chor YY, Cheng SMS, et al
    Phylogenetic Analysis of MERS-CoV in a Camel Abattoir, Saudi Arabia, 2016-2018.
    Emerg Infect Dis. 2020;26:3089-3091.
    PubMed         Abstract available

  86. SUAREZ DL, Pantin-Jackwood MJ, Swayne DE, Lee SA, et al
    Lack of Susceptibility to SARS-CoV-2 and MERS-CoV in Poultry.
    Emerg Infect Dis. 2020;26:3074-3076.
    PubMed         Abstract available

  87. MURAKAMI S, Kitamura T, Suzuki J, Sato R, et al
    Detection and Characterization of Bat Sarbecovirus Phylogenetically Related to SARS-CoV-2, Japan.
    Emerg Infect Dis. 2020;26:3025-3029.
    PubMed         Abstract available

  88. LAITON-DONATO K, Villabona-Arenas CJ, Usme-Ciro JA, Franco-Munoz C, et al
    Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2, Colombia.
    Emerg Infect Dis. 2020;26:2854-2862.
    PubMed         Abstract available

    Eur J Radiol

  89. ZHAO P, Pan Z, Yu T
    Corrigendum to "COV is a readily available quantitative indicator of metabolic heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer" [Eur. J. Radiol. 132 (2020) 109338].
    Eur J Radiol. 2020 Nov 13:109401. doi: 10.1016/j.ejrad.2020.109401.

  90. JAVOR D, Kaplan H, Kaplan A, Puchner SB, et al
    Deep learning analysis provides accurate COVID-19 diagnosis on chest computed tomography.
    Eur J Radiol. 2020;133:109402.
    PubMed         Abstract available

    Infect Control Hosp Epidemiol

  91. OKSANEN LAH, Sanmark E, Oksanen SA, Anttila VJ, et al
    Should we avoid colleagues in leisure time during COVID-19?
    Infect Control Hosp Epidemiol. 2020 Nov 13:1-5. doi: 10.1017/ice.2020.1320.

  92. LEROSE J, Merlo C, Duong P, Harden K, et al
    The Role of the Social Vulnerability Index in Personal Protective Equipment Shortages, Number of Cases, and Associated Mortality During the COVID-19 Pandemic in Michigan Skilled Nursing Facilities.
    Infect Control Hosp Epidemiol. 2020 Nov 13:1-10. doi: 10.1017/ice.2020.1318.
    PubMed         Abstract available

  93. JAMAL AJ, Mozafarihashjin M, Coomes E, Anceva-Sami S, et al
    Sensitivity of mid-turbinate versus nasopharyngeal swabs for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
    Infect Control Hosp Epidemiol. 2020 Nov 18:1-15. doi: 10.1017/ice.2020.1326.
    PubMed         Abstract available

  94. KHAN S, Tsang KK, Mertz D, Dolovich M, et al
    A Regional Canadian Expert Consensus on recommendations for restoring exercise and pulmonary function testing in low and moderate-high community COVID-19 prevalence settings.
    Infect Control Hosp Epidemiol. 2020 Nov 20:1-9. doi: 10.1017/ice.2020.1339.
    PubMed         Abstract available

  95. GANZ-LORD F, Segal KR, Rinke ML
    COVID-19 Symptoms, Duration, and Prevalence Among Healthcare Workers in the New York Metropolitan Area.
    Infect Control Hosp Epidemiol. 2020 Nov 20:1-26. doi: 10.1017/ice.2020.1334.
    PubMed         Abstract available

  96. HESS OCR, Armstrong-Novak JD, Doll M, Cooper K, et al
    The Impact of COVID-19 on Provider Usage of Electronic Hand Hygiene Monitoring Technology.
    Infect Control Hosp Epidemiol. 2020 Nov 20:1-10. doi: 10.1017/ice.2020.1336.
    PubMed         Abstract available

  97. SHAH VP, Hainy CM, Swift MD, Breeher LE, et al
    Unrecognized SARS-CoV-2 Seroprevalence among healthcare personnel in a low prevalence area.
    Infect Control Hosp Epidemiol. 2020 Nov 20:1-7. doi: 10.1017/ice.2020.1341.

  98. LEROSE J, Sandhu A, Polistico J, Ellsworth J, et al
    The Impact of COVID-19 Response on Central Line Associated Bloodstream Infections and Blood Culture Contamination Rates at a Tertiary Care Center in Greater Detroit Area.
    Infect Control Hosp Epidemiol. 2020 Nov 20:1-15. doi: 10.1017/ice.2020.1335.
    PubMed         Abstract available

  99. ARIZA-HEREDIA E, Frenzel E, Cantu S, Carlson M, et al
    Surveillance and Identification of Clusters of Health Care Workers with COVID-19: Multidimensional Interventions at a Comprehensive Cancer Center.
    Infect Control Hosp Epidemiol. 2020 Nov 13:1-21. doi: 10.1017/ice.2020.1315.
    PubMed         Abstract available

  100. LUSEBRINK J, Schildgen V, Schildgen O
    Pooling is an insufficient strategy to avoid health care staff to patient transmission of SARS-CoV-2.
    Infect Control Hosp Epidemiol. 2020 Nov 20:1-7. doi: 10.1017/ice.2020.1340.
    PubMed         Abstract available

  101. WU M, Xie C, Wu R, Shu Y, et al
    Epidemiological and clinical characteristics of SARS-CoV-2 infection among healthcare workers in Hubei Province of China.
    Infect Control Hosp Epidemiol. 2020 Nov 18:1-20. doi: 10.1017/ice.2020.1321.
    PubMed         Abstract available

    Int J Infect Dis

  102. GIANDHARI J, Pillay S, Wilkinson E, Tegally H, et al
    Early transmission of SARS-CoV-2 in South Africa: An epidemiological and phylogenetic report.
    Int J Infect Dis. 2020 Nov 12. pii: S1201-9712(20)32322.
    PubMed         Abstract available

  103. LI P, Wang Y, Peppelenbosch MP, Ma Z, et al
    Systematically comparing COVID-19 with 2009 influenza pandemic for hospitalized patients.
    Int J Infect Dis. 2020 Nov 12. pii: S1201-9712(20)32321.
    PubMed         Abstract available

  104. NGIAM JN, Chew N, Tham SM, Beh DL, et al
    Demographic shift in COVID-19 patients in Singapore from an aged, at-risk population to young, migrant workers with reduced risk of severe disease.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32467.
    PubMed         Abstract available

  105. KUMAR G, Adams A, Hererra M, Rojas ER, et al
    Predictors and Outcomes of HAIs in COVID-19 Patients.
    Int J Infect Dis. 2020 Nov 15. pii: S1201-9712(20)32447.
    PubMed         Abstract available

  106. TIWARI A, So MKP, Chong ACY, Chan JNL, et al
    Pandemic Risk of COVID-19 Outbreak in the United States: An Analysis of Network Connectedness with Air Travel Data.
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32454.
    PubMed         Abstract available

  107. VAN NGUYEN Q, Cao DA, Nghiem SH
    The Spread of COVID-19 and Policy Responses in Vietnam: An Overview.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32466.
    PubMed         Abstract available

  108. ILIC I, Zdravkovic M, Timcic S, Stojanovic DU, et al
    Pneumonia in medical professionals during COVID-19 outbreak in cardiovascular hospital.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32465.
    PubMed         Abstract available

  109. ALCOBA-FLOREZ J, Gil-Campesino H, Garcia-Martinez de Artola D, Diez-Gil O, et al
    Increasing SARS-CoV-2 RT-qPCR testing capacity by sample pooling.
    Int J Infect Dis. 2020 Nov 18. pii: S1201-9712(20)32468.
    PubMed         Abstract available

  110. BALKHAIR A, Al-Zakwani I, Al Busaidi M, Al-Khirbash A, et al
    Anakinra in hospitalized patients with severe COVID-19 pneumonia requiring oxygen therapy: results of a prospective, open-label, interventional study.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32458.
    PubMed         Abstract available

  111. FEDERGRUEN A, Naha S
    Crowding Effects Dominate Demographic Attributes in COVID-19 Cases.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32267.
    PubMed         Abstract available

  112. RABERAHONA M, Rakotomalala R, Rakotomijoro E, Rahaingoalidera T, et al
    Clinical and epidemiological features discriminating confirmed COVID-19 patients from SARS-CoV-2 negative patients at screening centres in Madagascar.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32462.
    PubMed         Abstract available

  113. DAIA C, Scheau C, Neagu G, Andone I, et al
    Nerve conduction study and electromyography findings in patients recovering from Covid-19 - case report.
    Int J Infect Dis. 2020 Nov 17. pii: S1201-9712(20)32455.
    PubMed         Abstract available

  114. PATRIQUIN G, LeBlanc JJ
    SARS-CoV-2 sensitivity limbo - how low can we go?
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32446.

  115. GORNY AW, Bagdasarian N, Koh Hong Kiat A, Lim YC, et al
    SARS-CoV-2 in Migrant Worker Dormitories: Geospatial Epidemiology Supporting Outbreak Management.
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32457.
    PubMed         Abstract available

  116. UDWADIA ZF, Singh P, Barkate H, Patil S, et al
    Efficacy and Safety of Favipiravir, an Oral RNA-Dependent RNA Polymerase Inhibitor, in Mild-to-Moderate COVID-19: A Randomized, Comparative, Open-Label, Multicenter, Phase 3 Clinical Trial.
    Int J Infect Dis. 2020 Nov 16. pii: S1201-9712(20)32453.
    PubMed         Abstract available

  117. ZOU H, Lu J, Liu J, Wong JH, et al
    Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis.
    Int J Infect Dis. 2020 Nov 14. pii: S1201-9712(20)32460.
    PubMed         Abstract available

  118. PATTERSON BK, Seethamraju H, Dhody K, Corley MJ, et al
    CCR5 Inhibition in Critical COVID-19 Patients Decreases Inflammatory Cytokines, Increases CD8 T-Cells, and Decreases SARS-CoV2 RNA in Plasma by Day 14.
    Int J Infect Dis. 2020 Nov 10. pii: S1201-9712(20)32305.
    PubMed         Abstract available

    Intensive Care Med

  119. VASQUES F, Sanderson B, Formenti F, Shankar-Hari M, et al
    Physiological dead space ventilation, disease severity and outcome in ventilated patients with hypoxaemic respiratory failure due to coronavirus disease 2019.
    Intensive Care Med. 2020;46:2092-2093.

  120. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.
    Intensive Care Med. 2020 Oct 29. pii: 10.1007/s00134-020-06294.
    PubMed         Abstract available

  121. MATTHAY MA, Arabi YM, Siegel ER, Ware LB, et al
    Phenotypes and personalized medicine in the acute respiratory distress syndrome.
    Intensive Care Med. 2020 Nov 18. pii: 10.1007/s00134-020-06296.
    PubMed         Abstract available

  122. ARINA P, Baso B, Moro V, Patel H, et al
    Discriminating between CPAP success and failure in COVID-19 patients with severe respiratory failure.
    Intensive Care Med. 2020 Nov 16. pii: 10.1007/s00134-020-06304.

  123. SALLUH JIF, Burghi G, Haniffa R
    Intensive care for COVID-19 in low- and middle-income countries: research opportunities and challenges.
    Intensive Care Med. 2020 Nov 13. pii: 10.1007/s00134-020-06285.

    J Infect

  124. XIONG X, Jiao X, Li H, Zeng S, et al
    Glucocorticoid benefits the ventilatory function of sever/critical COVID-19 patients.
    J Infect. 2020 Nov 18. pii: S0163-4453(20)30712.

  125. BAUER W, Diehl-Wiesenecker E, Ulke J, Galtung N, et al
    Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department.
    J Infect. 2020 Nov 17. pii: S0163-4453(20)30711.

  126. TORRES M, Collins K, Corbit M, Ramirez M, et al
    Comparison of Saliva and Nasopharyngeal Swab SARS-CoV-2 RT-qPCR Testing in a Community Setting.
    J Infect. 2020 Nov 17. pii: S0163-4453(20)30710.

  127. COLSON P, Finaud M, Levy N, Lagier JC, et al
    Evidence of SARS-CoV-2 re-infection with a different genotype.
    J Infect. 2020 Nov 15. pii: S0163-4453(20)30706.

  128. YAN Y, Jiang X, Fu J, Huang J, et al
    Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30701.

  129. CHAN RWY, Chan KC, Chan KYY, Lui GCY, et al
    SARS-CoV-2 detection by nasal strips: a superior tool for surveillance of pediatric population.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30704.

  130. GARDINER T, Cooke G, Fidler S, Cooper N, et al
    The under-representation of BAME patients in the COVID-19 Recovery trial at a major London NHS Trust.
    J Infect. 2020 Nov 12. pii: S0163-4453(20)30699.

  131. AUNG AK, Aitken T, Teh BM, Yu C, et al
    Angiotensin converting enzyme genotypes and mortality from COVID-19: An ecological study.
    J Infect. 2020 Nov 14. pii: S0163-4453(20)30708.
    PubMed         Abstract available

  132. RANA MS
    Clinical and laboratory characteristics of recovered versus deceased COVID-19 patients in Islamabad, Pakistan.
    J Infect. 2020 Nov 13. pii: S0163-4453(20)30705.

  133. HAMED E, Alnuaimi AS, Syed MA, Elhamid MA, et al
    Clinical characteristics of 51815 patients presenting with positive and negative SARS-CoV-2 swab results in primary health care settings.
    J Infect. 2020 Nov 13. pii: S0163-4453(20)30709.

  134. POOLE S, Brendish NJ, Clark TW
    SARS-CoV-2 has displaced other seasonal respiratory viruses: results from a prospective cohort study.
    J Infect. 2020 Nov 15. pii: S0163-4453(20)30707.
    PubMed         Abstract available

    J Med Virol

  135. VERALDI S, Spigariolo CB
    Pityriasis rosea and COVID-19.
    J Med Virol. 2020 Nov 18. doi: 10.1002/jmv.26679.
    PubMed         Abstract available

  136. TAKAGI H
    A red mirage - Did the association of the 2016 presidential election results with the COVID-19 epidemic magically disappear in 2020?
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26682.
    PubMed         Abstract available

  137. AKINOSOGLOU K, Gogos A, Papageorgiou C, Angelopoulos E, et al
    Ketamine in COVID-19 patients: Thinking out of the box.
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26681.
    PubMed         Abstract available

  138. GIULIANI J, Bonetti A
    COVID-19 and Cancer: A Clear Change Not Only in Daily Clinical Practice But Also in Clinical Research Management.
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26680.
    PubMed         Abstract available

  139. ALSHARRAH D, Alhaddad F, Alyaseen M, Aljamaan S, et al
    Clinical Characteristics of Pediatric SARS-CoV-2 Infection and Coronavirus Disease 2019 (COVID-19) in Kuwait.
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26684.
    PubMed         Abstract available

  140. TALMY T, Tsur A, Shabtay O
    Duration of SARS-CoV-2 Detection in Israel Defense Forces Soldiers with Mild COVID-19.
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26374.
    PubMed         Abstract available

  141. MERCATELLI D, Triboli L, Fornasari E, Ray F, et al
    coronapp: A Web Application to Annotate and Monitor SARS-CoV-2 Mutations.
    J Med Virol. 2020 Nov 18. doi: 10.1002/jmv.26678.
    PubMed         Abstract available

  142. FAVRESSE J, Cadrobbi J, Eucher C, Elsen M, et al
    Clinical performances of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26669.
    PubMed         Abstract available

  143. SEYMEN CM
    The other side of COVID-19 pandemic: Effects on male fertility.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26667.
    PubMed         Abstract available

  144. ATEYA AM, Sabri NA
    Angiotensin-converting enzyme inhibitors (ACEIs) and Angiotensin-receptor blockers (ARBs) benefits outweigh the risks in COVID-19 hypertensive patients.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26672.
    PubMed         Abstract available

  145. AWAN UA, Zahoor S, Ayub A, Ahmed H, et al
    COVID-19 and Arboviral Diseases: Another Challenge for Pakistan's Delipidated Healthcare System.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26668.

  146. SWAMINATHAN N, Moussa P, Mody N, Bryan Lo K, et al
    COVID-19 in HIV infected patients: A Case series and Literature Review.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26671.
    PubMed         Abstract available

  147. SPOTO S, Agro FE, Sambuco F, Travaglino F, et al
    High value of Mid-regional proAdrenomedullin in COVID-19: a marker of widespread endothelial damage, disease severity and mortality.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26676.
    PubMed         Abstract available

  148. YANG J, Tian C, Chen Y, Zhu C, et al
    Obesity aggravates COVID-19: an updated systematic review and meta-analysis.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26677.
    PubMed         Abstract available

  149. HILL JA, Menon MP, Dhanireddy S, Wurfel MM, et al
    Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26674.
    PubMed         Abstract available

  150. SYAL K
    Newly identified limitations of diagnostic tools for COVID-19 and consequences.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26673.
    PubMed         Abstract available

    J Travel Med

  151. EBRAHIM SH, Ahmed Y, Alqahtani SA, Memish ZA, et al
    The Hajj pilgrimage during the COVID-19 pandemic in 2020: event hosting without the mass gathering.
    J Travel Med. 2020 Nov 13. pii: 5979518. doi: 10.1093.

  152. KHATIB AN, Carvalho AM, Primavesi R, To K, et al
    Navigating the Risks of Flying During COVID-19: A Review for Safe Air Travel.
    J Travel Med. 2020 Nov 12. pii: 5976283. doi: 10.1093.
    PubMed         Abstract available

    J Virol

  153. MILEWSKA A, Chi Y, Szczepanski A, Barreto-Duran E, et al
    HTCC as a Polymeric Inhibitor of SARS-CoV-2 and MERS-CoV.
    J Virol. 2020 Nov 20. pii: JVI.01622-20. doi: 10.1128/JVI.01622.
    PubMed         Abstract available


  154. RICHTERMAN A, Meyerowitz EA, Cevik M
    Hospital-Acquired SARS-CoV-2 Infection: Lessons for Public Health.
    JAMA. 2020 Nov 13. pii: 2773128. doi: 10.1001/jama.2020.21399.

  155. KUEHN BM
    Partnership to Make 120 Million COVID-19 Rapid Tests Available.
    JAMA. 2020;324:1933.

  156. MANABE YC, Sharfstein JS, Armstrong K
    The Need for More and Better Testing for COVID-19.
    JAMA. 2020 Nov 13. pii: 2773129. doi: 10.1001/jama.2020.21694.

  157. DATTA SD, Talwar A, Lee JT
    A Proposed Framework and Timeline of the Spectrum of Disease Due to SARS-CoV-2 Infection: Illness Beyond Acute Infection and Public Health Implications.
    JAMA. 2020 Nov 18. pii: 2773338. doi: 10.1001/jama.2020.22717.

  158. LURIE N, Experton B
    How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign.
    JAMA. 2020 Nov 19. pii: 2773348. doi: 10.1001/jama.2020.22720.

  159. VAHIA IV, Jeste DV, Reynolds CF 3rd
    Older Adults and the Mental Health Effects of COVID-19.
    JAMA. 2020 Nov 20. pii: 2773479. doi: 10.1001/jama.2020.21753.

  160. WANG EA, Western B, Berwick DM
    COVID-19, Decarceration, and the Role of Clinicians, Health Systems, and Payers: A Report From the National Academy of Sciences, Engineering, and Medicine.
    JAMA. 2020 Nov 16. pii: 2773226. doi: 10.1001/jama.2020.22109.


    Global health: time for radical change?
    Lancet. 2020;396:1129.

  162. ZIMERMAN A, Lopes RD, D'Avila A, Rohde LE, et al
    COVID-19 in Brazil: the headlines should be about science.
    Lancet. 2020 Nov 10. pii: S0140-6736(20)32375.

  163. FORE HH, Ghebreyesus TA, Watkins K, Greenslade L, et al
    Leveraging the COVID-19 response to end preventable child deaths from pneumonia.
    Lancet. 2020 Nov 11. pii: S0140-6736(20)32348.

  164. FREUDENTHAL R, Horowitz M, Jadhav S, Moncrieff J, et al
    Lack of safeguards in response to restrictive public health measures.
    Lancet. 2020;396:e70.

  165. PONIKOWSKI P, Kirwan BA, Anker SD, McDonagh T, et al
    Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32339.
    PubMed         Abstract available

    Lancet Glob Health

  166. ACHARYA R, Porwal A
    Estimating vulnerability to COVID-19 in India - Authors' reply.
    Lancet Glob Health. 2020;8:e1467.

  167. REDDY KP, Shebl FM, Foote JHA, Harling G, et al
    Cost-effectiveness of public health strategies for COVID-19 epidemic control in South Africa: a microsimulation modelling study.
    Lancet Glob Health. 2020 Nov 11. pii: S2214-109X(20)30452.
    PubMed         Abstract available

  168. GINSBURG AS, Klugman KP
    COVID-19 pneumonia and the appropriate use of antibiotics.
    Lancet Glob Health. 2020;8:e1453-e1454.

  169. MALANI A, Shah D, Kang G, Lobo GN, et al
    Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India.
    Lancet Glob Health. 2020 Nov 13. pii: S2214-109X(20)30467.

  170. HOMER CSE, Leisher SH, Aggarwal N, Akuze J, et al
    Counting stillbirths and COVID 19-there has never been a more urgent time.
    Lancet Glob Health. 2020 Nov 16. pii: S2214-109X(20)30456.

  171. KIM R, Subramanian SV
    Estimating vulnerability to COVID-19 in India.
    Lancet Glob Health. 2020;8:e1464.

  172. BASU S
    Estimating vulnerability to COVID-19 in India.
    Lancet Glob Health. 2020;8:e1465.

  173. DWIVEDI LK, Bansal A
    Estimating vulnerability to COVID-19 in India.
    Lancet Glob Health. 2020;8:e1466.

    Lancet Infect Dis

  174. BAR-ZEEV N, Kochhar S
    Expecting the unexpected with COVID-19 vaccines.
    Lancet Infect Dis. 2020 Nov 17. pii: S1473-3099(20)30870.

  175. PEIFFER-SMADJA N, Rebeaud ME, Guihur A, Mahamat-Saleh Y, et al
    Hydroxychloroquine and COVID-19: a tale of populism and obscurantism.
    Lancet Infect Dis. 2020 Nov 13. pii: S1473-3099(20)30866.

  176. ZHANG Y, Zeng G, Pan H, Li C, et al
    Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial.
    Lancet Infect Dis. 2020 Nov 17. pii: S1473-3099(20)30843.
    PubMed         Abstract available

    Lancet Neurol

  177. DEL CARMEN ORTEGA M, Borrel JM, de Jesus Bermejo T, Gonzalez-Lamuno D, et al
    Lessons from individuals with Down syndrome during COVID-19.
    Lancet Neurol. 2020;19:974-975.

  178. MUPPIDI S, Guptill JT, Jacob S, Li Y, et al
    COVID-19-associated risks and effects in myasthenia gravis (CARE-MG).
    Lancet Neurol. 2020;19:970-971.

    Lancet Oncol

  179. GOURD E
    Lung cancer control in the UK hit badly by COVID-19 pandemic.
    Lancet Oncol. 2020 Nov 12. pii: S1470-2045(20)30691.

  180. CHALLINOR JM, Alqudimat MR, Teixeira TOA, Oldenmenger WH, et al
    Oncology nursing workforce: challenges, solutions, and future strategies.
    Lancet Oncol. 2020 Nov 16. pii: S1470-2045(20)30605.
    PubMed         Abstract available

    Lancet Planet Health

  181. HINSLEY S
    Planetary health research digest.
    Lancet Planet Health. 2020;4:e140.

    Lancet Psychiatry

  182. LESKE S, Kolves K, Crompton D, Arensman E, et al
    Real-time suicide mortality data from police reports in Queensland, Australia, during the COVID-19 pandemic: an interrupted time-series analysis.
    Lancet Psychiatry. 2020 Nov 16. pii: S2215-0366(20)30435.
    PubMed         Abstract available

  183. GHOSH M, Chatterji BP
    Mental health insurance in India after COVID-19.
    Lancet Psychiatry. 2020;7:1016-1017.

  184. ARANGO C, Wykes T, Moreno C
    Mental health care and COVID-19.
    Lancet Psychiatry. 2020;7:1013.

  185. PATRA S, Patro BK
    COVID-19 and adolescent mental health in India.
    Lancet Psychiatry. 2020;7:1015.

  186. SIFAT RI
    The effect of COVID-19 on hijra (third gender) people in Bangladesh.
    Lancet Psychiatry. 2020;7:1015-1016.

  187. KING C, Bennett M, Fulford KWM, Clarke S, et al
    From Preproduction to Coproduction: COVID-19, whiteness, and making black mental health matter.
    Lancet Psychiatry. 2020 Nov 12. pii: S2215-0366(20)30458.

    Lancet Respir Med

  188. NIMMO C, Agbetile J, Bhowmik A, Capocci S, et al
    Implementing rapid diagnostics for COVID-19.
    Lancet Respir Med. 2020 Nov 12. pii: S2213-2600(20)30526.

  189. PEIFFER-SMADJA N, Yazdanpanah Y
    Nebulised interferon beta-1a for patients with COVID-19.
    Lancet Respir Med. 2020 Nov 12. pii: S2213-2600(20)30523.

  190. MONK PD, Marsden RJ, Tear VJ, Brookes J, et al
    Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet Respir Med. 2020 Nov 12. pii: S2213-2600(20)30511.
    PubMed         Abstract available

  191. DANDEL M
    Pathophysiology of COVID-19-associated acute respiratory distress syndrome.
    Lancet Respir Med. 2020 Nov 13. pii: S2213-2600(20)30507.

  192. NARAYAN A, Garg P, Arora U, Ray A, et al
    Pathophysiology of COVID-19-associated acute respiratory distress syndrome.
    Lancet Respir Med. 2020 Nov 13. pii: S2213-2600(20)30509.

  193. GRASSELLI G, Tonetti T, Filippini C, Slutsky AS, et al
    Pathophysiology of COVID-19-associated acute respiratory distress syndrome - Authors' reply.
    Lancet Respir Med. 2020 Nov 13. pii: S2213-2600(20)30525.

  194. D'CRUZ RF, Perrin F, Birring SS, Patel AS, et al
    Provision of holistic care after severe COVID-19 pneumonia: anticipating clinical need and managing resources.
    Lancet Respir Med. 2020 Nov 13. pii: S2213-2600(20)30529.

  195. TSOLAKI V, Zakynthinos GE, Mantzarlis K, Vazgiourakis V, et al
    Pathophysiology of COVID-19-associated acute respiratory distress syndrome.
    Lancet Respir Med. 2020 Nov 13. pii: S2213-2600(20)30506.

  196. CAMPOROTA L, Chiumello D, Busana M, Gattinoni L, et al
    Pathophysiology of COVID-19-associated acute respiratory distress syndrome.
    Lancet Respir Med. 2020 Nov 13. pii: S2213-2600(20)30505.

  197. DHAWAN RT, Gopalan D, Howard L, Vicente A, et al
    Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19.
    Lancet Respir Med. 2020 Nov 17. pii: S2213-2600(20)30407.
    PubMed         Abstract available

    Life Sci

  198. SABIRLI R, Koseler A, Goren T, Turkcuer I, et al
    High GRP78 levels in Covid-19 infection: A case-control study.
    Life Sci. 2020 Nov 18:118781. doi: 10.1016/j.lfs.2020.118781.
    PubMed         Abstract available

  199. LANG Y, Chen K, Li Z, Li H, et al
    The nucleocapsid protein of zoonotic betacoronaviruses is an attractive target for antiviral drug discovery.
    Life Sci. 2020 Nov 12:118754. doi: 10.1016/j.lfs.2020.118754.
    PubMed         Abstract available

    MMWR Morb Mortal Wkly Rep

  200. COVID-19 Stats: COVID-19 Incidence,* by Urban-Rural Classification(dagger) - United States, January 22-October 31, 2020( section sign).
    MMWR Morb Mortal Wkly Rep. 2020;69:1753.

  201. THOMPSON CN, Baumgartner J, Pichardo C, Toro B, et al
    COVID-19 Outbreak - New York City, February 29-June 1, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1725-1729.
    PubMed         Abstract available

  202. YI SH, See I, Kent AG, Vlachos N, et al
    Characterization of COVID-19 in Assisted Living Facilities - 39 States, October 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1730-1735.
    PubMed         Abstract available

  203. DENNY TN, Andrews L, Bonsignori M, Cavanaugh K, et al
    Implementation of a Pooled Surveillance Testing Program for Asymptomatic SARS-CoV-2 Infections on a College Campus - Duke University, Durham, North Carolina, August 2-October 11, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1743-1747.
    PubMed         Abstract available

  204. HSU CH, Rehman MS, Bullard K, Jorba J, et al
    Progress Toward Poliomyelitis Eradication - Pakistan, January 2019-September 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1748-1752.
    PubMed         Abstract available

  205. Erratum: Vol. 69, No. 43: COVID-19-Associated Hospitalizations Among Health Care Personnel - COVID-NET, 13 States, March 1-May 31, 2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:1711.

    N Engl J Med

  206. RUBIN EJ, Baden LR, Haug CJ, Morrissey S, et al
    Audio Interview: Covid-19 in Europe and New Information on Vaccines.
    N Engl J Med. 2020;383:e134.

  207. Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
    N Engl J Med. 2020;383:e119.

  208. RUBIN EJ, Baden LR, Morrissey S
    Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
    N Engl J Med. 2020;383:e123.

  209. MANZANO GS, Woods JK, Amato AA
    Covid-19-Associated Myopathy Caused by Type I Interferonopathy.
    N Engl J Med. 2020 Nov 20. doi: 10.1056/NEJMc2031085.


  210. WHITE P
    Long COVID: don't consign ME/CFS to history.
    Nature. 2020;587:197.

  211. ADAM D
    Simulating the pandemic: What COVID forecasters can learn from climate models.
    Nature. 2020 Nov 13. pii: 10.1038/d41586-020-03208.

    COVID vaccine excitement builds as Moderna reports third positive result.
    Nature. 2020;587:337-338.

  213. ZHOU P, Yang XL, Wang XG, Hu B, et al
    Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin.
    Nature. 2020 Nov 17. pii: 10.1038/s41586-020-2951.

  214. AKCIL A, Sun Z, Panda S
    COVID-19 disruptions to tech-metals supply are a wake-up call.
    Nature. 2020;587:365-367.

    Tired of science being ignored? Get political.
    Nature. 2020;586:337.

  216. DEPAUL A
    How to shift into COVID-19 research.
    Nature. 2020 Nov 20. pii: 10.1038/d41586-020-03298.

  217. YU X, Cragg MS
    Engineered antibodies to combat viral threats.
    Nature. 2020 Nov 18. pii: 10.1038/d41586-020-03196.

  218. Europe must think more globally in crafting its pandemic response.
    Nature. 2020;587:329.

    Pol J Radiol

  219. BRESSEM KK, Adams LC, Albrecht J, Petersen A, et al
    Is lung density associated with severity of COVID-19?
    Pol J Radiol. 2020;85:e600-e606.
    PubMed         Abstract available


    What is the Performance and Role of CT in Suspected COVID-19 Infection?
    Radiology. 2020 Nov 17:2040130. doi: 10.1148/radiol.20202040130.

  221. SCHALEKAMP S, Bleeker-Rovers CP, Beenen LFM, Quarles van Ufford HME, et al
    Chest CT in the Emergency Department for Diagnosis of COVID-19 Pneumonia: Dutch Experience.
    Radiology. 2020 Nov 17:203465. doi: 10.1148/radiol.2020203465.
    PubMed         Abstract available

  222. SONG F, Shi N, Shan F, Zhang Z, et al
    Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia.
    Radiology. 2020;297:E346.


    India's COVID-19 teacher.
    Science. 2020;370:752-753.

  224. BLASIMME A, Vayena E
    What's next for COVID-19 apps? Governance and oversight.
    Science. 2020;370:760-762.

  225. KIELIAN M
    Enhancing host cell infection by SARS-CoV-2.
    Science. 2020;370:765-766.

  226. COHEN J
    Vaccine wagers on coronavirus surface protein pay off.
    Science. 2020;370:894-895.

  227. HOU YJ, Chiba S, Halfmann P, Ehre C, et al
    SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo.
    Science. 2020 Nov 12. pii: science.abe8499. doi: 10.1126/science.abe8499.
    PubMed         Abstract available

    Travel Med Infect Dis

  228. PRIYANKA, Choudhary OP, Singh I
    Protective immunity against COVID-19: Unravelling the evidences for humoral vs. cellular components.
    Travel Med Infect Dis. 2020 Nov 10:101911. doi: 10.1016/j.tmaid.2020.101911.

  229. MEDEIROS DA SILVA RC, Nogueira Marinho LC, Neto de Araujo Silva D, Costa de Lima K, et al
    Saliva as a possible tool for the SARS-CoV-2 detection: a review.
    Travel Med Infect Dis. 2020 Nov 18:101920. doi: 10.1016/j.tmaid.2020.101920.
    PubMed         Abstract available

  230. NOVOA RH, Quintana W, Llancari P, Urbina-Quispe K, et al
    Maternal clinical characteristics and perinatal outcomes among pregnant women with Coronavirus Disease 2019. A systematic review.
    Travel Med Infect Dis. 2020 Nov 18:101919. doi: 10.1016/j.tmaid.2020.101919.
    PubMed         Abstract available

  231. HOU J, Hong J, Ji B, Dong B, et al
    Changed transmission epidemiology of COVID-19 at early stage: A nationwide population-based piecewise mathematical modelling study.
    Travel Med Infect Dis. 2020 Nov 12:101918. doi: 10.1016/j.tmaid.2020.101918.

  232. GOUMBALLA N, Dieng M, Sokha C, Gautret P, et al
    Lack of SARS-CoV-2 among Grand Magal de Touba pilgrims consulting for respiratory symptoms in October 2020.
    Travel Med Infect Dis. 2020;39:101916.

  233. BIELECKI M, Patel D, Hinkelbein J, Komorowski M, et al
    Air travel and COVID-19 prevention in the pandemic and peri-pandemic period: A narrative review.
    Travel Med Infect Dis. 2020;39:101915.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO COVID-19 is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.